UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
V.I. TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE
--------------------------------------------------------------------------------
(Title of Class of Securities)
917920100
-------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosure provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes.)
CUSIP NO. 917920100
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
New York Blood Center, Inc.
13-1949477
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
Not Applicable
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 2,359,704 shares
SHARES ----------------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
None
OWNED BY
----------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 2,359,704 shares
PERSON ----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
WITH
None
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,359,704 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
Not Applicable
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.5% (as of June 30, 2001)
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
ITEM 1.
(a) Name of Issuer:
V.I. Technologies, Inc.
(b) Address of Issuer's Principal Executive Offices:
134 Coolidge Avenue
Watertown, Massachusetts 02472
ITEM 2.
(a) Name of Person Filing:
New York Blood Center, Inc.
(b) Address of Principal Business Office or, if none, Residence:
310 East 67th Street
New York, New York 10021
(c) Citizenship:
New York
(d) Title of Class of Securities:
Common Stock, $.01 par value
(e) CUSIP Number:
917920100
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13-1(B), OR 13D-2(B), CHECK
WHETHER THE PERSON FILING IS A:
Not Applicable
ITEM 4. OWNERSHIP
(a) Amount beneficially owned
2,359,704
(b) Percent of class:
10.5% (as of June 30, 2001)
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 2,359,704 shares
(ii) Shared power to vote or to direct the vote: None
(iii) Sole power to dispose or to direct the disposition of:
2,359,704 shares
(iv) Shared power to dispose or to direct the disposition of: None
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not Applicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
ITEM 10. CERTIFICATION
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
September 10, 2001
NEW YORK BLOOD CENTER, INC.
By: /S/ LARRY HANNIGAN
-------------------------------
Name: Larry Hannigan
Title: Chief Financial Officer